NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Pediatric Gastroenterology and Nutrition - JPGN

• Publication date

  2017-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MPG.0000000000001482PMID 28107283PMCID PMC5413933
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.

  2016cited by this paper
• Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents.

  2016cited by this paper
• Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

  2015cited by this paper
• Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

  2015cited by this paper
• Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.

  2015cited by this paper
• Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis

  2015cited by this paper
• Indications and Limitations of Bariatric Intervention in Severely Obese Children and Adolescents With and Without Nonalcoholic Steatohepatitis: ESPGHAN Hepatology Committee Position Statement

  2015cited by this paper
• Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese American Children

  2015cited by this paper
• Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion‐weighted MRI measurements in adults

  2015cited by this paper
• The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH.

  2015cited by this paper
• Response to Challenge Dose Among Young Adults Vaccinated for Hepatitis B as Infants: Importance of Detectable Residual Antibody to Hepatitis B Surface Antigen

  2015cited by this paper
• Is it time to advance pediatric NAFLD diagnosis to the magnetic resonance imaging era?

  2015cited by this paper
• Improvement in Liver Histology Is Associated With Reduction in Dyslipidemia in Children With Nonalcoholic Fatty Liver Disease

  2015cited by this paper
• Relation Between Vitamin D Status and Nonalcoholic Fatty Liver Disease in Children

  2015cited by this paper
• Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease

  2015cited by this paper
• Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.

  2015cited by this paper
• Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.

  2015cited by this paper
• Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease.

  2015cited by this paper
• A 4-Polymorphism Risk Score Predicts Steatohepatitis in Children With Nonalcoholic Fatty Liver Disease

  2014cited by this paper
• Secondhand tobacco exposure is associated with nonalcoholic fatty liver disease in children.

  2014cited by this paper
• Dietary Fructose Reduction Improves Markers of Cardiovascular Disease Risk in Hispanic-American Adolescents with NAFLD

  2014cited by this paper
• Evidence and recommendations for imaging liver fat in children, based on systematic review.

  2014cited by this paper
• Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease.

  2014cited by this paper
• Low serum 25‐hydroxyvitamin D concentrations associate with non‐alcoholic fatty liver disease in adolescents independent of adiposity

  2014cited by this paper
• Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non‐alcoholic steatohepatitis

  2014cited by this paper
• Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease.

  2014cited by this paper
• Co-morbidity resolution in morbidly obese children and adolescents undergoing sleeve gastrectomy.

  2014cited by this paper
• Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease.

  2014cited by this paper
• The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease

  2014cited by this paper
• Weight Loss in Nonalcoholic Fatty Liver Disease Patients in an Ambulatory Care Setting Is Largely Unsuccessful but Correlates with Frequency of Clinic Visits

  2014cited by this paper
• Predicting hepatic steatosis in a racially and ethnically diverse cohort of adolescent girls.

  2014cited by this paper
• Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease.

  2014cited by this paper
• Longitudinal Assessment of High Blood Pressure in Children with Nonalcoholic Fatty Liver Disease

  2014cited by this paper
• A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease.

  2014cited by this paper
• Severe Obesity in Children and Adolescents: Identification, Associated Health Risks, and Treatment Approaches A Scientific Statement From the American Heart Association

  2013cited by this paper
• Transient Elastography Is a Useful Noninvasive Tool for the Evaluation of Fibrosis in Paediatric Chronic Liver Disease

  2013cited by this paper
• Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease

  2013cited by this paper
• Liver steatosis assessment: correlations among pathology, radiology, clinical data and automated image analysis software.

  2013cited by this paper
• Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010.

  2013cited by this paper
• Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children

  2013cited by this paper
• Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease

  2013cited by this paper
• Serum Cytokeratin-18 Fragment Levels Are Useful Biomarkers for Nonalcoholic Steatohepatitis in Children

  2013cited by this paper
• Sonography-guided percutaneous liver biopsies in children.

  2013cited by this paper
• Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children.

  2013cited by this paper
• The Relationship Between Pediatric Nonalcoholic Fatty Liver Disease and Cardiovascular Risk Factors and Increased Risk of Atherosclerosis in Obese Children

  2013cited by this paper
• Effect of Operator Experience and Frequency of Procedure Performance on Complication Rate After Ultrasound-Guided Percutaneous Liver Biopsies

  2013cited by this paper
• A Low-Glycemic-Load versus Low-Fat Diet in the Treatment of Fatty Liver in Obese Children

  2013cited by this paper
• Meta-Regression Analyses, Meta-Analyses, and Trial Sequential Analyses of the Effects of Supplementation with Beta-Carotene, Vitamin A, and Vitamin E Singly or in Different Combinations on All-Cause Mortality: Do We Have Evidence for Lack of Harm?

  2013cited by this paper
• Nonalcoholic fatty liver disease in severely obese adolescent and adult patients

  2013cited by this paper
• Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.

  2013cited by this paper
• The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice

  2013cited by this paper
• Genetic and Clinical Markers of Elevated Liver Fat Content in Overweight and Obese Hispanic Children

  2013cited by this paper
• Serum Bilirubin Level Is Inversely Associated With Nonalcoholic Steatohepatitis in Children

  2013cited by this paper
• A Multidisciplinary Clinical Program Is Effective in Stabilizing BMI and Reducing Transaminase Levels in Pediatric Patients With NAFLD

  2013cited by this paper
• Changes in weight and co-morbidities among adolescents undergoing bariatric surgery: 1-year results from the Bariatric Outcomes Longitudinal Database.

  2013cited by this paper
• Ultrasonography as a non-invasive tool for detection of nonalcoholic fatty liver disease in overweight/obese Egyptian children.

  2012cited by this paper
• Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research

  2012cited by this paper
• A trial of sugar-free or sugar-sweetened beverages and body weight in children.

  2012cited by this paper
• Effects of Aerobic Versus Resistance Exercise Without Caloric Restriction on Abdominal Fat, Intrahepatic Lipid, and Insulin Sensitivity in Obese Adolescent Boys

  2012cited by this paper
• Effectiveness and safety of ultrasound-guided percutaneous liver biopsy in children

  2012cited by this paper
• The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy

  2012cited by this paper
• Non-invasive markers of liver fibrosis in chronic liver disease in a group of Mexican children. A multicenter study.

  2012cited by this paper
• Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children.

  2012cited by this paper
• Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes

  2012cited by this paper
• Longitudinal Effects of MRI-Measured Hepatic Steatosis on Biomarkers of Glucose Homeostasis and Hepatic Apoptosis in Obese Youth

  2012cited by this paper
• Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).

  2012cited by this paper
• Diagnosis of Nonalcoholic Fatty Liver Disease in Children and Adolescents: Position Paper of the ESPGHAN Hepatology Committee

  2012cited by this paper
• Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.

  2012cited by this paper
• Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

  2012cited by this paper
• A randomized trial of sugar-sweetened beverages and adolescent body weight.

  2012cited by this paper
• Patterns of surgical weight loss and resolution of metabolic abnormalities in superobese bariatric adolescents.

  2012cited by this paper
• Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge

  2012cited by this paper
• Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents

  2012cited by this paper
• Effect of a 10-week Weight Loss Camp on Fatty Liver Disease and Insulin Sensitivity in Obese Danish Children

  2012cited by this paper
• Two-year outcome of laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity: results from a Swedish Nationwide Study (AMOS)

  2012cited by this paper
• Laparoscopic sleeve gastrectomy in obese adolescents: results in 51 patients.

  2012cited by this paper
• Short‐Term Psychological Outcomes in Severely Obese Adolescents After Bariatric Surgery

  2012cited by this paper
• Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

  2012cited by this paper
• Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy.

  2012cited by this paper
• Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement

  2011cited by this paper
• Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.

  2011cited by this paper
• A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis.

  2011cited by this paper
• Hepatitis B and the need for a booster dose.

  2011cited by this paper
• Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.

  2011cited by this paper
• Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report

  2011cited by this paper
• Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease.

  2011cited by this paper
• Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial

  2011cited by this paper
• Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease

  2011cited by this paper
• Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver.

  2011cited by this paper
• Biochemical Parameters and Anthropometry Predict NAFLD in Obese Children

  2011cited by this paper
• Interventions for preventing obesity in children.

  2011cited by this paper
• Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

  2011cited by this paper
• Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity-related Liver Disease

  2011cited by this paper
• Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16 390 overweight or obese children and adolescents

  2010cited by this paper
• Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease

  2010cited by this paper
• A prospective trial for laparoscopic adjustable gastric banding in morbidly obese adolescents: an interim report of weight loss, metabolic and quality of life outcomes.

  2010cited by this paper
• Symptoms and quality of life in obese children and adolescents with non‐alcoholic fatty liver disease

  2010cited by this paper
• Severity of Liver Injury and Atherogenic Lipid Profile in Children With Nonalcoholic Fatty Liver Disease

  2010cited by this paper
• Safety of Blind Percutaneous Liver Biopsy in Obese Children A Retrospective Analysis

  2010cited by this paper
• Screening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement

  2010cited by this paper

• Identification of dinner dietary patterns and their association with metabolic risk factors and anthropometric indices in adults with non-alcoholic fatty liver disease.

  2026cites this paper
• Longitudinal changes in vibration-controlled transient elastography in pediatric fatty liver disease.

  2026cites this paper
• Clinical and microbial correlates of response to lifestyle intervention in pediatric metabolic dysfunction-associated steatotic liver disease

  2026cites this paper
• Quantitative assessment of liver stiffness using 2D-shear wave elastography in Egyptian children suspected metabolically-dysfunction-associated steatotic liver disease

  2026cites this paper
• Exploring the link between metabolic dysfunction-associated fatty liver disease and subclinical hypothyroidism in adolescents: a comprehensive review.

  2026cites this paper
• The epidemiology of metabolic dysfunction-associated steatotic liver disease among pediatric patients with type 2 diabetes: Systematic review and meta-analysis

  2026cites this paper
• Bridging the gap in paediatric MASLD screening: progress, pitfalls and the path ahead.

  2026cites this paper
• Fat-Soluble Vitamins: Deficiency and Excess.

  2026cites this paper
• Endotoxin Markers Are Elevated in Adolescents With Obesity With and Without Metabolic Dysfunction‐Associated Steatotic Liver Disease

  2026cites this paper
• Clinical Course and Predictors of Metabolic Dysfunction Associated Steatotic Liver Disease in Obese Children and Adolescents.

  2026cites this paper
• Etiology and clinical features of hypertransaminasemia in children: A retrospective study from a tertiary care center in Türkiye

  2026cites this paper
• Exploring metabolic etiologies of MAFLD in children with normal BMI

  2026cites this paper
• Liver Fat Is Associated With Elevated FGF21 in Youth With Obesity but Without MASLD

  2026cites this paper
• Worry, Rumination, and Metacognitive Beliefs in Adolescents with Obesity Associated with Binge Eating Disorder (BED) vs. Age-Matched Adolescents with Essential Obesity: A Cross-Sectional Study

  2026cites this paper
• Resistance training for metabolic dysfunction-associated steatotic liver disease:a systematic review and meta-analysis

  2026cites this paper
• From Childhood to Old Age: Current Knowledge and Practical Approaches to Metabolic Dysfunction-Associated Steatotic Liver Disease.

  2026cites this paper
• Examining Biomarkers for Dyslipidemia, Diabetes, and NAFLD by CDC's 2022 Extended BMI Percentiles in US Youth Aged 6–17 Years

  2025cites this paper
• Impact of COVID-19 on BMI Status and Comorbidities in New Patients Presenting to a Pediatric Weight Management Clinic: A Retrospective Study From January 2017 to June 2023

  2025cites this paper
• The pediatric medical liver biopsy: indications, procedures, and histopathology

  2025cites this paper
• Serum LEAP-2 as a Potential Biomarker for Hepatic Steatosis in Adolescents with Obesity and MASLD: A Cross-Sectional Study

  2025cites this paper
• Metabolic dysfunction-associated steatotic liver disease and dietary intake characteristics in children and adolescents: A cross-sectional study.

  2025cites this paper
• Childhood Obesity and Its Physiological Association with Sugar-Sweetened, Free-Sugar Juice, and Artificially Sweetened Beverages

  2025cites this paper
• The impact of hepatic steatosis on epicardial adipose tissue in obese individuals

  2025influential citation
• Machine learning fibrosis score for pediatric metabolic dysfunction-associated steatotic liver disease: Promising but premature

  2025cites this paper
• The Predictive Role of the Triglyceride/High-Density Lipoprotein Ratio and the Triglyceride–Glucose Index, Along with Anthropometric Measurements, in Diagnosing Non-Alcoholic Fatty Liver Disease in Obese Kids and Juveniles, and the Evaluation of Novel Cardiovascular Risk Markers in Pediatric NAFLD

  2025cites this paper
• From traditional metabolic markers to ensemble learning: comparative application of machine learning models for predicting NAFLD risk in adolescents

  2025cites this paper
• Concurrent Increase in Fatty Acid Oxidation and Fatty acid Synthesis: A Unique Metabolic State in a Pig Model of Pediatric Steatotic Liver Disease.

  2025cites this paper
• The association of serum uric acid level and the uric acid to creatinine ratio with non alcoholic fatty liver disease in children with obesity

  2025cites this paper
• Complementary use of autoantibody detection methods facilitates diagnosis of juvenile autoimmune hepatitis and autoimmune sclerosing cholangitis

  2025cites this paper
• Preliminary evidence of improved liver biomarkers in adolescents with obesity and suspected metabolic dysfunction‐associated steatotic liver disease treated with semaglutide: A case series

  2025cites this paper
• Starting Age for Screening Metabolic Dysfunction‐Associated Steatotic Liver Disease in Children Using Controlled Attenuation Parameter on Transient Elastography

  2025cites this paper
• Assessment of Guideline‐Recommended Laboratory Screening for Obesity‐Related Chronic Conditions in US Youth 10–18 Years

  2025cites this paper
• Hepatic fat and dietary intake as determinants of metabolic health in obese adolescents: a cross-sectional MRI study

  2025cites this paper
• ALT and novel fibrosis scores for risk stratification of pediatric MASLD.

  2025cites this paper
• Assessment of hepatic steatosis in children with metabolic dysfunction-associated steatotic liver disease using ultrasound derived fat fraction: first large-scale clinical evaluation

  2025cites this paper
• AASLD Practice Statement on the evaluation and management of metabolic dysfunction-associated steatotic liver disease in children.

  2025cites this paper
• Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease in Children with Down Syndrome at a Tertiary Care Center

  2025cites this paper
• Consensus Statement on Metabolic Dysfunction‐Associated Steatotic Liver Disease in Children and Adolescents From the Joint TASL‐TSPGHAN Expert Committee

  2025cites this paper
• Future potential therapeutics to treat MASH.

  2025cites this paper
• Relationship between the systemic immune-inflammatory index and overactive bladder risk: A cross-sectional assessment involving United States Adults

  2025cites this paper
• Markers of Early Liver Dysfunction Associate With Reduced Heart Rate Variability in Adolescents With Type 1 Diabetes

  2025cites this paper
• Secondary Hypertension in Children—Identifying and Investigating at Risk Children

  2025cites this paper
• Metabolic dysfunction-associated steatotic liver disease is associated with the risk of severe liver fibrosis in pediatric population

  2025cites this paper
• Sonographic evidence of hepatic steatosis is highly prevalent in at‐risk children under 4 years of age

  2025cites this paper
• Analysis of Dietary Behavior and Quality in Children and Adolescents with Non-alcoholic Fatty Liver Disease Using the Korean Nutrition Quotient Score

  2025cites this paper
• Associations Between Serum Gut-Derived Tryptophan Metabolites and Cardiovascular Health Markers in Adolescents with Obesity

  2025cites this paper
• Ability of triglyceride‐glucose indices to predict metabolic dysfunction associated with steatotic liver disease in pediatric obesity

  2025cites this paper
• Metabolic Dysfunction-Associated Steatotic Liver Disease in Children with Obesity: Sex-Stratified Analysis of Hepatic Enzyme Profiles and Serum Uric Acid

  2025cites this paper
• Evaluation of tri‐ponderal mass index in predicting metabolic associated fatty liver disease in obese children

  2025influential citation
• Glucagon-Like Peptide-2 as a Potential Biomarker for Nonalcoholic Fatty Liver Disease in Children with Obesity: Preliminary Assessment of Metabolic Associations and Underlying Mechanisms

  2025cites this paper
• Reclassifying pediatric NAFLD using the steatotic liver disease framework: a multicenter retrospective study from the NASH CRN.

  2025cites this paper
• Prevalence and characteristics of metabolic dysfunction-associated steatohepatitis among pediatric patients in the MarketScan Databases

  2025cites this paper
• Screening and diagnosis of metabolic dysfunction-associated steatotic liver disease in children within public healthcare.

  2025cites this paper
• The evolving landscape of pediatric obesity and metabolic dysfunction-associated steatotic liver disease

  2025cites this paper
• Efficacy of non-pharmacological treatments in pediatric MASLD: a review of the literature

  2025cites this paper
• A rare etiology of hepatic steatosis.

  2025cites this paper
• Rising burden of metabolic dysfunction-associated steatotic liver disease in adolescents aged 15-19 years and projections to 2035.

  2025cites this paper
• Association between early-life exposure to mercury and cardiometabolic risk factors development in adolescence.

  2025cites this paper
• Childhood Obesity Prevalence and Prevention Strategies in Primary Care: A Comprehensive Review

  2025cites this paper
• Efficacy of pharmacotherapies on pediatric patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis

  2025cites this paper
• Early-Life Nutritional Determinants of Pediatric MASLD

  2025cites this paper
• Diagnosis and Management of Pediatric Non-Alcoholic Fatty Liver Disease: An Overview

  2025cites this paper
• [Meta analysis of the prevalence and risk factors of non-alcoholic fatty liver disease in overweight and obese children and adolescents in China].

  2025cites this paper
• Full-length 16S rRNA Sequencing Reveals Gut Microbiome Signatures Predictive of MASLD in children with obesity

  2025cites this paper
• Antiobesity medications in adult and pediatric obesity and metabolic dysfunction-associated steatotic liver disease.

  2025cites this paper
• Clinical Features and Plasma Metabolites Analysis in Obese Chinese Children With Nonalcoholic Fatty Liver Disease

  2025cites this paper
• Association of blood manganese and selenium levels with hepatic steatosis among adolescents: a nationwide cross-sectional analysis

  2025cites this paper
• Sex Differences in Body Composition and MASLD in Children With Overweight and Obesity

  2025cites this paper
• Association of antinuclear antibody positivity with liver disease severity in pediatric metabolic dysfunction-associated steatotic liver disease

  2025cites this paper
• Integrating Machine Learning and Follow-Up Variables to Improve Early Detection of Hepatocellular Carcinoma in Tyrosinemia Type 1: A Multicenter Study

  2025cites this paper
• Steatotic Liver Disease: Navigating Pathologic Features, Diagnostic Challenges, and Emerging Insights.

  2025cites this paper
• Prevalence and Predictors of Suspected Metabolic Dysfunction‐Associated Steatotic Liver Disease in Adolescents in the United States

  2025cites this paper
• Challenges in Promoting Physical Activity for Managing MASLD in Canadian Children: Insights and Barriers

  2025cites this paper
• KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025

  2025cites this paper
• Long-Term Effects of a Responsive Parenting Intervention on Child Weight Outcomes Through Age 9 Years: The INSIGHT Randomized Clinical Trial.

  2025cites this paper
• Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease

  2025cites this paper
• The association between hepatic steatosis, vitamin D status, and insulin resistance in adolescents with obesity

  2025cites this paper
• Elevated Alpha-Fetoprotein Levels in Children with Metabolic Dysfunction-Associated Liver Disease

  2025cites this paper
• Association of metabolic evaluation of visceral fat score with nonalcoholic fatty liver disease and liver fibrosis: A cross-sectional study based on NHANES

  2025cites this paper
• A bibliometric analysis of metabolic dysfunction-associated steatotic liver disease in children from 2004 to 2024

  2025cites this paper
• Noninvasive Assessment of Nonalcoholic Fatty Liver Disease in Children with Overweight and Obesity by Transient Elastography

  2025cites this paper
• The correlation of apolipoprotein B and apolipoprotein A1 with metabolic dysfunction‐associated steatotic liver disease in children and adolescents with obesity

  2025cites this paper
• Non-invasive diagnosis and prognosis of MASH with fibrosis F2-F3: In need for a tailored, accessible, and affordable solution for the 21st century public health epidemic.

  2025cites this paper
• Metabolic dysfunction-associated steatotic liver disease in children: a practical update based on Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN) 2024 guidelines

  2025cites this paper
• Comparison of Ultrasound-Based Techniques and Magnetic Resonance Imaging Proton Density Fat Fraction in Measuring the Amount of Hepatic Fat in Children with Hepatosteatosis

  2025cites this paper
• Overview of Metabolic Dysfunction-Associated Steatohepatitis in Children.

  2025cites this paper
• ALT is an effective screening tool for advanced MASLD in children with obesity and overweight.

  2025cites this paper
• Call to action - pediatric MASLD requires immediate attention to curb health crisis.

  2025cites this paper
• Optimal cutoffs of fatty liver index and hepatic steatosis index in diagnosing pediatric MASLD.

  2025cites this paper
• Metabolic Dysfunction‐Associated Steatotic Liver Disease in an Urban Paediatric Cohort With High Socioeconomic Deprivation

  2025cites this paper
• Complications of obesity in children and youths with type 1 diabetes mellitus

  2025cites this paper
• Obesity alters metabolic profiles in children with acute pancreatitis, but not disease severity and recurrence: a Romanian cohort study

  2025cites this paper
• Ultrasound screening for cystic echinococcosis of school-age children in endemic areas of Chile: A pilot cross-sectional study towards integration in the Regional Program for the Elimination of Cystic Echinococcosis 2020–2029

  2025cites this paper
• Classification of childhood obesity using longitudinal clinical body mass index and its validation

  2025cites this paper
• Weight gain in infancy and metabolic dysfunction-associated steatotic liver disease (MASLD) in a prospective birth cohort of Latino children

  2025cites this paper
• The evolving landscape of pediatric hepatology: key updates and future directions.

  2025cites this paper
• MAFLD outperforms NAFLD in identifying metabolic dysfunction in U.S. adolescents: a NHANES 2017–2020 analysis

  2025cites this paper
• A Comparison of Novel Serum Markers of Liver Health in Adolescents With Metabolic Dysfunction‐Associated Steatotic Liver Disease

  2025cites this paper
• Consensus on the diagnosis, treatment, and follow-up in children and adolescents with overweight and obesity of the Latin American Society for Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN).

  2025cites this paper
• Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025

  2025influential citation